News
Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 ...
Novo Nordisk faces slowing revenue growth, weak Q2 2025 results, and a more conservative outlook. Read why I rate NVO stock a ...
AP Moller-Maersk shares rose in Copenhagen after the company reported strong earnings for the second quarter.
Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo ...
COMPANY ANNOUNCEMENT No. 230/2025 Tvis, 6 August 2025 TCM Group A/S revise full year guidance for 2025 As the closing of the ...
Orion Oyj Series A posted the largest decline among large stocks during the session, declining 7.8%, followed by Embla Medical hf. shares, which declined 7.7%. Shares of Orion Oyj Series B declined ...
The drugmaker released its second-quarter earnings report early Wednesday as it vowed to cut costs amid intensifying ...
Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of ...
Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...
The dollar was flat. There has been a "small softening" in risk sentiment, NAB's Tapas Strickland said, citing softness in the ISM services report released overnight and Trump's plan to roll out ...
Amidst challenging market environment DSV’s Q2 performance was bolstered by early gains from its acquisition of Schenker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results